<DOC>
	<DOC>NCT02079675</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy and safety of different doses of SKI3246 compared with placebo in the treatment of patients with irritable bowel syndrome with non-constipation.</brief_summary>
	<brief_title>Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Have been diagnosed as nonconstipation by ROME III. Patients who voluntarily signed written informed consent may participate in the study. Pregnant or lactating female. Patients with a history of inflammatory bowel disease. Severe neurological or psychological disease History of allergic reaction to the medications used in this study Use of other investigational drugs within 30 days prior to the study. Patients that investigators consider ineligible for this study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>